Pradaxa (Dabigatran) Bleeding Rates No Higher Than Warfarin, Says FDA

Bleeding rates linked to new use of Pradaxa (Dabigatran) are no higher than they are with new users of warfarin, says a new FDA Drug Safety communication report update (November 2, 2012). The FDA (Food and Drug Administration) carried out an evaluation on Pradaxa after receiving several post-marketing reports of bleeding among new users... via Health News from Medical News Today Read More Here..